PEDIATRICS Vol. 100 No. 6 December 1997, pp. 987-993
Received Nov 26, 1996; accepted Apr 16, 1997.
,
,
, and
From the Departments of * Pediatrics and
Epidemiology and
Biostatistics, Case Western Reserve University School of Medicine,
Cleveland, Ohio;§ University Hospitals, Cleveland, Ohio;
MetroHealth
Medical Center, Cleveland, Ohio; and ¶ Fairview General Hospital,
Cleveland, Ohio.
Objective. Bronchopulmonary dysplasia (BPD) is now the leading cause of lung disease in US infants. In a large regional cohort, we tested the hypothesis that despite innovations in neonatal care, very low birth weight (VLBW) infants (<1500 g) with BPD had poorer developmental outcomes than nonaffected infants during the first 3 years of life, and that BPD predicted poorer outcome beyond the effects of other risk factors.
Methods. Three groups of infants (122 with BPD, 84 VLBW without BPD, and 123 full-term) were followed longitudinally to 3 years of age with the Bayley Scales of Mental and Motor Development. Comparison groups of VLBW infants without BPD and full-term infants did not differ in sex, race, or socioeconomic status. Statistical analyses included hierarchical and stepwise multiple regression.
Results. Infants with BPD performed more poorly at all ages. By 3 years, cognitive and/or motor development was in the range of retardation (<70 standard score) for 21% to 22% of infants with BPD. In multiple regression analyses controlling for socioeconomic and neonatal risk conditions, BPD had an independent negative effect on motor outcome at 3 years. Neurologic risk, a summary measure of neurologic problems other than intraventricular hemorrhage, and the presence of BPD independently predicted motor delay. By 3 years, social class, race, and neurologic risk predicted mental outcome, suggesting that the specific effects of BPD are primarily on the motor domain.
Conclusions. In VLBW infants, BPD predicts poorer motor outcome at 3 years, after control for other risks. Cohorts of infants with BPD also had higher rates of mental retardation, associated with greater neurologic and social risk. These findings underscore the need for intensive prevention and habilitation efforts for this growing group of VLBW survivors, as well as investigation into the potential role of BPD in the higher rates of learning disabilities in VLBW cohorts at school age.
Key words: bronchopulmonary dysplasia, very low birth weight, infant development, chronic lung disease, surfactant, socioeconomic status.
This article has been cited by other articles:
![]() |
K. Kobaly, M. Schluchter, N. Minich, H. Friedman, H. G. Taylor, D. Wilson-Costello, and M. Hack Outcomes of Extremely Low Birth Weight (<1 kg) and Extremely Low Gestational Age (<28 Weeks) Infants With Bronchopulmonary Dysplasia: Effects of Practice Changes in 2000 to 2003 Pediatrics, January 1, 2008; 121(1): 73 - 81. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Short, H. L. Kirchner, G. R. Asaad, S. E. Fulton, B. A. Lewis, N. Klein, S. Eisengart, J. Baley, C. Kercsmar, M. O. Min, et al. Developmental Sequelae in Preterm Infants Having a Diagnosis of Bronchopulmonary Dysplasia: Analysis Using a Severity-Based Classification System Arch Pediatr Adolesc Med, November 1, 2007; 161(11): 1082 - 1087. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Wilkinson, D. M. Brosi, and Z. D. Jiang Functional Impairment of the Brainstem in Infants With Bronchopulmonary Dysplasia Pediatrics, August 1, 2007; 120(2): 362 - 371. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. C. Brown, L. W. Doyle, M. J. Bear, and T. E. Inder Alterations in Neurobehavior at Term Reflect Differing Perinatal Exposures in Very Preterm Infants Pediatrics, December 1, 2006; 118(6): 2461 - 2471. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. Washburn, P. A. Nixon, and T. M. O'Shea Follow-up of a Randomized, Placebo-Controlled Trial of Postnatal Dexamethasone: Blood Pressure and Anthropometric Measurements at School Age Pediatrics, October 1, 2006; 118(4): 1592 - 1599. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M Black and A. Baqui Reply to E Pollitt Am. J. Clinical Nutrition, July 1, 2005; 82(1): 201 - 202. [Full Text] [PDF] |
||||
![]() |
A. R. Laptook, T. M. O' Shea, S. Shankaran, B. Bhaskar, and and the NICHD Neonatal Network Adverse Neurodevelopmental Outcomes Among Extremely Low Birth Weight Infants With a Normal Head Ultrasound: Prevalence and Antecedents Pediatrics, March 1, 2005; 115(3): 673 - 680. [Abstract] [Full Text] [PDF] |
||||
![]() |
N S Wood, K Costeloe, A T Gibson, E M Hennessy, N Marlow, A R Wilkinson, and for the EPICure Study Group The EPICure study: associations and antecedents of neurological and developmental disability at 30 months of age following extremely preterm birth Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2005; 90(2): F134 - F140. [Abstract] [Full Text] [PDF] |
||||
![]() |
K J Collard, S Godeck, J E Holley, and M W Quinn Pulmonary antioxidant concentrations and oxidative damage in ventilated premature babies Arch. Dis. Child. Fetal Neonatal Ed., September 1, 2004; 89(5): F412 - F416. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Short, N. K. Klein, B. A. Lewis, S. Fulton, S. Eisengart, C. Kercsmar, J. Baley, and L. T. Singer Cognitive and Academic Consequences of Bronchopulmonary Dysplasia and Very Low Birth Weight: 8-Year-Old Outcomes Pediatrics, November 1, 2003; 112(5): e359 - 359. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Schmidt, E. V. Asztalos, R. S. Roberts, C. M. T. Robertson, R. S. Sauve, M. F. Whitfield, and for the Trial of Indomethacin Prophylaxis in Prete Impact of Bronchopulmonary Dysplasia, Brain Injury, and Severe Retinopathy on the Outcome of Extremely Low-Birth-Weight Infants at 18 Months: Results From the Trial of Indomethacin Prophylaxis in Preterms JAMA, March 5, 2003; 289(9): 1124 - 1129. [Abstract] [Full Text] [PDF] |
||||
![]() |
B Bohm and M Katz-Salamon Cognitive development at 5.5 years of children with chronic lung disease of prematurity Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2003; 88(2): F101 - F105. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. T. D'Angio, R. A. Sinkin, T. P. Stevens, N. K. Landfish, J. L. Merzbach, R. M. Ryan, D. L. Phelps, D. R. Palumbo, and G. J. Myers Longitudinal, 15-Year Follow-up of Children Born at Less Than 29 Weeks' Gestation After Introduction of Surfactant Therapy Into a Region: Neurologic, Cognitive, and Educational Outcomes Pediatrics, December 1, 2002; 110(6): 1094 - 1102. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. E. Vaucher Bronchopulmonary Dysplasia: An Enduring Challenge Pediatr. Rev., October 1, 2002; 23(10): 349 - 358. [Full Text] [PDF] |
||||
![]() |
J. M. Briet, L. van Sonderen, M. Buimer, K. Boer, and J. H. Kok Neurodevelopmental Outcome of Children Treated With Antenatal Thyrotropin-Releasing Hormone Pediatrics, August 1, 2002; 110(2): 249 - 253. [Abstract] [Full Text] [PDF] |
||||
![]() |
P L Clark, I I Ekekezie, H A Kaftan, C A Castor, and W E Truog Safety and efficacy of nitric oxide in chronic lung disease Arch. Dis. Child. Fetal Neonatal Ed., January 1, 2002; 86(1): F41 - 45. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Snodgrass, V.V. Vedanarayanan, C. C. Parker, and B. R. Parks Pediatric Patients With Undetectable Anticonvulsant Blood Levels: Comparison With Compliant Patients J Child Neurol, March 1, 2001; 16(3): 164 - 168. [Abstract] [PDF] |
||||
![]() |
S. A. Abrams Chronic Pulmonary Insufficiency in Children and Its Effects on Growth and Development J. Nutr., March 1, 2001; 131(3): 938S - 941. [Abstract] [Full Text] |
||||
![]() |
M. Hack, D. Wilson-Costello, H. Friedman, G. H. Taylor, M. Schluchter, and A. A. Fanaroff Neurodevelopment and Predictors of Outcomes of Children With Birth Weights of Less Than 1000 g: 1992-1995 Arch Pediatr Adolesc Med, July 1, 2000; 154(7): 725 - 731. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Katz-Salamon, E M Gerner, B Jonsson, and H Lagercrantz Early motor and mental development in very preterm infants with chronic lung disease Arch. Dis. Child. Fetal Neonatal Ed., July 1, 2000; 83(1): 1F - 6. [Abstract] [Full Text] |
||||
![]() |
B. R. Vohr, L. L. Wright, A. M. Dusick, L. Mele, J. Verter, J. J. Steichen, N. P. Simon, D. C. Wilson, S. Broyles, C. R. Bauer, et al. Neurodevelopmental and Functional Outcomes of Extremely Low Birth Weight Infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993-1994 Pediatrics, June 1, 2000; 105(6): 1216 - 1226. [Abstract] [Full Text] |
||||
![]() |
M. Palta, M. Sadek-Badawi, M. Evans, M. R. Weinstein, G. McGuinness, and for the Newborn Lung Project Functional Assessment of a Multicenter Very Low-Birth-Weight Cohort at Age 5 Years Arch Pediatr Adolesc Med, January 1, 2000; 154(1): 23 - 30. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. T. Singer, A. Salvator, S. Guo, M. Collin, L. Lilien, and J. Baley Maternal Psychological Distress and Parenting Stress After the Birth of a Very Low-Birth-Weight Infant JAMA, March 3, 1999; 281(9): 799 - 805. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Banks, I. Seri, H. Ischiropoulos, J. Merrill, J. Rychik, and R. A. Ballard Changes in Oxygenation With Inhaled Nitric Oxide in Severe Bronchopulmonary Dysplasia Pediatrics, March 1, 1999; 103(3): 610 - 618. [Abstract] [Full Text] |
||||
![]() |
R. Arendt, J. Angelopoulos, A. Salvator, and L. Singer Motor Development of Cocaine-exposed Children at Age Two Years Pediatrics, January 1, 1999; 103(1): 86 - 92. [Abstract] [Full Text] [PDF] |
||||